News for hackers. Stuff that matters.
Re:Multiple sclerosis has a common viral culprit, opening do... by colechristensen on Saturday August 13, 2022 @08:59PM (#32455292)
Where isn’t this true unless you’re rich and connected?
Re:Multiple sclerosis has a common viral culprit, opening do... by doctor_eval on Saturday August 13, 2022 @09:23PM (#32455445)
Australia? MS clinics around the country are free under Medicare, as is treatment. My friend is receiving twice annual infusions of Ocrelizumab. It literally costs them nothing.

I mean you can argue that Australia is a rich country, but it’s available to any citizen regardless of wealth.

Re:Multiple sclerosis has a common viral culprit, opening do... by ipaddr on Saturday August 13, 2022 @11:18PM (#32456030)
You first need to get someone to prescribe Ocrelizumab
Re:Multiple sclerosis has a common viral culprit, opening do... by doctor_eval on Sunday August 14, 2022 @01:30AM (#32456656)
That really was not a problem.
Re:Multiple sclerosis has a common viral culprit, opening do... by refurb on Sunday August 14, 2022 @04:48AM (#32457629)
https://www.msaustralia.org.au/news/subsidy-recommendations-...

It's not available if you have early, MRI-active primary progressive MS. PBAC decided not to reimbursement ocrelizumab for that.

Re:Multiple sclerosis has a common viral culprit, opening do... by Broken_Hippo on Sunday August 14, 2022 @06:18AM (#32458057)
Many if not most countries have preferred front-line treatments, usually decided by a combination of overall costs. These costs will include things like actual monetary cost, how closely you need to be monitored by your doctors (blood tests and stuff), how severe side effects are, how much the reduce disability in the long term, the ability of patients to stick with it and things like that.
Re:Multiple sclerosis has a common viral culprit, opening do... by refurb on Sunday August 14, 2022 @07:15AM (#32458318)
Right. And some countries choose to have first-line treatments that prioritize lower cost over efficacy of therapy. It's great as a taxpayer, not so great at a patient.
Re:Multiple sclerosis has a common viral culprit, opening do... by rj9000 on Sunday August 14, 2022 @09:43PM (#32464984)
Some countries prescribe Rituximab as quasi off-label for MS. Basically same drug for all intents and purposes as Ocrevus.

I think Sweden uses Rituximab openly for MS. In the US I've heard some neuros prescribe Rituximab if insurance won't cover O.

Re:Multiple sclerosis has a common viral culprit, opening do... by refurb on Sunday August 14, 2022 @10:00PM (#32465062)
Rituximab was shown to be inferior in a head to head comparison against ocrelizumab.
Re:Multiple sclerosis has a common viral culprit, opening do... by nso on Saturday August 13, 2022 @09:50PM (#32455600)
Most of europe
Re:Multiple sclerosis has a common viral culprit, opening do... by tazjin on Saturday August 13, 2022 @10:01PM (#32455651)
In most parts of Europe getting to a specialist (e.g. a neurologist in this case) may still involve a long wait.
Re:Multiple sclerosis has a common viral culprit, opening do... by tluyben2 on Sunday August 14, 2022 @01:48AM (#32456748)
That’s because people trust their gp; if you don’t, you get referred fast. At least where I have lived and I am on public healthcare; experience with NL ES PT UK BE; never have to wait for anything.
Re:Multiple sclerosis has a common viral culprit, opening do... by nxm on Sunday August 14, 2022 @05:52AM (#32457942)
No, in Poland it’s because there is simply a long wait for on and not because people trust their gp (quite the opposite in many cases)
Re:Multiple sclerosis has a common viral culprit, opening do... by Broken_Hippo on Sunday August 14, 2022 @06:19AM (#32458062)
That's the case in many places of the US as well.